Bausch & Lomb to Update Investors At UBS Warburg Global Life Sciences Conference On October 8, 2002.

Business Editors

ROCHESTER, N.Y.--(BUSINESS WIRE)--Oct. 3, 2002

Bausch & Lomb (NYSE:BOL) announced today that its Chief Financial Officer, Stephen C. McCluski, will be presenting an overview of the Company's operations at the UBS Warburg Global Life Sciences Conference in New York, NY, on Tuesday, October 8, 2002.

The presentation will be posted on the Investor Relations page of the Company's web site, www.bausch.com, following the conference.

Bausch & Lomb Incorporated is the preeminent global technology-based healthcare company for the eye, dedicated to helping consumers see, look and feel better through innovative technology and design. Its core businesses include soft and rigid gas permeable contact lenses, lens care products, ophthalmic surgical and pharmaceutical products. The Company is advantaged with some of the most respected brands in the world starting with its name, Bausch & Lomb(R), and including SofLens(TM), PureVision(TM), Boston(R), ReNu(R), Storz(R) and Technolas(TM). Founded in 1853 in Rochester, N.Y., where it continues to have its headquarters, the Company has annual revenues of approximately $1.7 billion and employs approximately 12,000 people in more than 50 countries. Bausch & Lomb products are available in more than 100 countries around the world. More information about the Company can be found on Bausch & Lomb's Web site at www.bausch.com. Copyright Bausch & Lomb.